2018年12月2日星期日

[HTML] Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

[HTML] Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

NG Jørgensen, SM Ahmad, N Abildgaard… - Stem cell …, 2016 - ncbi.nlm.nih.gov
Abstract The B-cell lymphoma-2 (Bcl-2) family of proteins play a crucial role in multiple
myeloma (MM), contributing to lacking apoptosis which is a hallmark of the disease. This
makes the Bcl-2 proteins interesting targets for therapeutic peptide vaccination. We report a …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论